Læknablaðið - 15.02.1997, Qupperneq 45

LÆKNABLAÐIÐ 1997; 83
117
Fræðigreinar íslenskra lækna í erlendum tímaritum
Getið er fræðigreina og -ágripa. Sendið
heiti greinar, nöfn höfunda og birtingarstað tii
Læknablaðsins. Miðað er við greinar sem
birst hafa á yfirstandandi og síðasta ári. Til
glöggvunar verður íslenskra höfunda getið
með fornafni þótt þess sé ekki getið við birt-
ingu.
* Brynjólfur Jónsson, Sernbo I, Carlsson Á, Fre-
din H, Johnell O. Social function after cervical hip
fracture. A comparison of hook-pins and total hip
replacement in 47 patients. Acta Orthop Scand
1996;67:431-4.
* María Bjarnadóttir, Grubb A, ísleifur Ólafsson.
Promoter-mediated, dexamethasone-induced
increase in cystatin C production by HeLa cells.
Scand J Clin Lab Invest 1995; 55: 617-23.
* ísleifur Ólafsson. The human cystatin C gene
promoter: functional analysis and identification of
hetergeneous mRNA. Scand J Clin Lab Invest
1995; 55: 597-607.
* ísleifur Ólafsson, Leifur Þorsteinsson, Ólafur
Jensson. The Molecular Pathology of Hereditary
Cystatin C Amyloid Angiopathy Causing Brain
Hemorrhage. Brain Patho 1996; 6:121-6.
* Karl Andersen, Dellborg M, Swedberg K. Nucle-
oside Transport Inhibition with Draflazine in Un-
stable Coronary Disease. Eur J Clin Pharm 1996;
51: 7-13.
* Karl Andersen, Eriksson P, Kállström G, Dell-
borg M. Clinical evaluation is related to markers
of risk in patients with unstable angina pectoris
(abstract). XVth Nordic Congress of Cardiology,
Malmö, 1995.
* Karl Andersen, Dellborg M, Emanuelsson H,
Grip L, Swedberg K. Thrombin Inhibition with
Inogatran for Unstable Angina Pectoris: Evi-
dence of Reactivated Ischemia after Cessation of
Short-Term Treatment. Coronary Artery Disease
1996; 7: 673-81.
* Karl Andersen, Dellborg M, Emanuelsson H,
Grip L, Rydén L, Swedberg K. Reaktiverad ische-
mi efter avslutad behandling med trombin hám-
maren Inogatran vid instabil angina (abstrakt).
Svenska Lákaresállskapets Riksstámma, 1995.
* Karl Andersen, Dellborg M, Eriksson P, Káll-
ström G, Svensson A-M. Vektorkardiografi iden-
tifierar högrisk patienter med instabil angina (ab-
strakt). Svenska Lákaresállskapets Riksstámma
1995.
* Karl Andersen, Dellborg M, Eriksson P, Káll-
ström G, Svensson A-M. Vektorkardiografi iden-
tifierar tyst ischemi vid instabil angina (abstrakt).
Svenska Lákaresállskapets Riksstámma 1995.
* Karl Andersen, Eriksson P, Dellborg M. Non-
Invasive Risk Stratification within 48 Hours of
Hospital Admission in Patients with Unstable Co-
ronary Disease. Eur Heart J 1997 (in press).
* Karl Andersen, Eriksson P, Kállström G, Svens-
son A-M, Dellborg M. Ischaemia Detected by
Continuous On-Line Vectorcardiographic Mon-
itoring Predicts Unfavorable Outcome in Patients
Admitted with Probable Unstable Coronary Dis-
ease. Coronary Artery Disease 1996; 7: 753-60.
* Karl Andersen, Eriksson P, Kállström G, Svens-
son A-M, Dellborg M. Continuous Vectorcardiog-
raphy Predicts Early Clinical Events in Patients
with Unstable Coronary Disease (abstract). Eur
Heart J 1996; 17: 576.
* Karl Andersen, Eriksson P, Kállström G, Svens-
son A-M, Dellborg M. Continuous Vectorcardiog-
raphy Predicts Clinical Events in Patients with
Unstable Coronary Artery Disease (abstract).
Eur Heart J 1996; 17: 575.
* Karl Andersen, Eriksson P, Kállström G, Alf-
vegren E, Dellborg M. Heparin is more Effective
than Inogatran, a Novel Low-Molecular Weight
Thrombin Inhibitor in Unstable Coronary Disease
(abstract). J Am Coll Cardiol 1997: 27 (Supple-
ment A).
* Karl Andersen. Vectorcardiographic ST-Seg-
ment Monitoring in the Unstable Coronary Syn-
drome (thesis). Göteborg University, 1997.